Search results
How Long Can You Sustain Weight Loss on Wegovy? New Research Might Have the Answer
Health via Yahoo News· 4 days agoNew research shows that people who take Wegovy may keep the weight off for for four years and that...
An Ozempic alternative helps people lose weight without as many side effects, study says
Quartz· 10 hours agoZealand Pharma surged 23% after it announced positive clinical trial results for its experimental...
I lost 42 pounds with Ozempic, but was shaken by the drug's psychological toll
TODAY via Yahoo News· 1 day ago“My appetite was just dramatically dialed down from that point on. I was so much less hungry than...
Cheaper Versions of Popular New Weight-Loss Drugs Are Being Developed
Scientific American· 12 hours agoBlockbuster weight-loss drugs such as Wegovy could soon become a lot cheaper — and reach more people...
'Novo Nordisk is ripping off the American people,' Bernie Sanders says of Ozempic and Wegovy costs
NBC News via Yahoo News· 1 day agoSen. Bernie Sanders says the first question he is going to ask Novo Nordisk's CEO at a committee...
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters via Yahoo News· 5 hours agoEli Lilly on Friday said its popular weight-loss drug Zepbound helped resolve moderate to severe...
Lawsuit could challenge trust in Ozempic and other popular weight loss drugs
The Conversation via Yahoo News· 2 days agoPhillip/AP Photo The manufacturers of the most popular weight loss drugs are being challenged in...
‘I woke up paralysed, with no speech’: Inside the weight-loss drug black market
The Telegraph via Yahoo News· 10 hours agoThe World Health Organisation (WHO) has issued a global alert about the potential dangers posed by...
The Best Could Be Yet to Come for Novo Nordisk and Ozempic
Motley Fool via Yahoo Finance· 12 hours agoNordisk (NYSE: NVO) becoming one of the most valuable healthcare companies in the world. But as well...
Obesity-Drug Developers Look at What’s Next for a $100 Billion Market
Barrons.com· 1 day agoOppenheimer analyst Jay Olson spent several days last week listening as companies such as Eli Lilly...